CRINETICS PHARMACEUTICALS IN

Ticker: CRNX CUSIP: 22663K107 Class: EQTY

Schonfeld Strategic Advisors LLC's Holding History (CIK: 0001665241)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 81,847 Value ($000) $3,409 Avg Close $31.97 Range $25.83 - $47.41
Q2 2025
Shares 147,923 Value ($000) $4,254 Avg Close $30.88 Range $24.10 - $34.68
Q1 2025
Shares 19,192 Value ($000) $644 Avg Close $37.35 Range $31.65 - $53.55
Q4 2024
Shares 445,946 Value ($000) $22,801 Avg Close $55.95 Range $49.48 - $62.53
Q3 2024
Shares 490,725 Value ($000) $25,076 Avg Close $51.57 Range $43.71 - $55.78
Q2 2024
Shares 653,557 Value ($000) $29,273 Avg Close $46.18 Range $41.01 - $53.70
Q1 2024
Shares 135,293 Value ($000) $6,333 Avg Close $39.13 Range $33.67 - $47.58
Q4 2023
Shares 67,293 Value ($000) $2,394 Avg Close $30.67 Range $25.35 - $37.88
Q3 2023
Shares 277,208 Value ($000) $8,244 Avg Close $20.61 Range $15.76 - $31.00
Q1 2023
Shares 73,890 Value ($000) $1,187 Avg Close $18.51 Range $15.23 - $21.65
Q4 2021
Shares 18,600 Value ($000) $528 Avg Close $24.65 Range $18.97 - $28.82
Q3 2021
Shares 21,500 Value ($000) $453 Avg Close $20.92 Range $16.68 - $25.50
Q2 2021
Shares 21,800 Value ($000) $411 Avg Close $17.57 Range $15.15 - $21.64